FOI release

MAH: Glenmark Pharmaceuticals Europe Ltd

Some or all of the information requested may not have been provided because we determined that the request was vexatious.

Case reference FOI2026/00814

Received 24 July 2026

Published 14 September 2026

Request

I would like to request for Module 2.4, Module 2.5 and Module 2.7 submitted for Cyanocobalamin 50 microgram Film-coated Tablets, MAH: Glenmark Pharmaceuticals Europe Ltd, (PL 25258/0369).

Response

See attached

Documents

• FOI2026_00814 (redacted).pdf (719.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.